Overview of Current Synthetics - PowerPoint PPT Presentation

1 / 35
About This Presentation
Title:

Overview of Current Synthetics

Description:

Overview of Current Synthetics Darrell L. Davis Laboratory Director DEA South Central Laboratory Dallas, Texas Thanks! Darrell.L.Davis_at_usdoj.gov 972-559-7950 Rashad.A ... – PowerPoint PPT presentation

Number of Views:55
Avg rating:3.0/5.0
Slides: 36
Provided by: ccaCourt
Category:

less

Transcript and Presenter's Notes

Title: Overview of Current Synthetics


1
Overview of Current Synthetics
  • Darrell L. Davis
  • Laboratory Director
  • DEA South Central Laboratory
  • Dallas, Texas

2
Objectives
  • Discuss Spice/K2/Cannabinoid/Bath Salts
  • Discuss DEA Scheduling Procedures

3
SPICE/K2/CANNABINOIDS
4
SPICE
  • Unregulated mixture of dried herbs
  • Ingredients are commonly listed as Indian
    Warrior and Wild Dagga or Lions Tail
  • Each of which are potentially bioactive herbs
  • No mention of additives or other compounds that
    have a pharmacological activity

5
(No Transcript)
6
What are they?
7
Spice Facts Street Names
  • Spice
  • Spice Gold
  • Kush
  • Legal Eagle
  • Earth Impact
  • Scope
  • Spice Egypt
  • K2
  • Sence
  • Yucatan Fire
  • Smoke
  • Gorillaz
  • Skunk
  • Genie
  • Galaxy
  • Gold
  • Space Truckin
  • Solar Flare
  • Moon Rocks
  • Blue Lotus
  • Aroma
  • ChillX
  • Highdis
  • Almdrohner

8
Spice Facts
  • Street names
  • K2
  • Fake Weed
  • Spice
  • Spice Gold
  • Yucatan Gold
  • Skunk
  • Genie
  • Voodoo
  • Effects
  • hallucinations
  • severe agitation
  • elevated heart rate
  • elevated blood pressure
  • red eyes
  • mood alteration

www.sciencedaily.com
9
A Little Background
  • Synthetic cannabinoids were created in an attempt
    to manufacture a legitimate pharmaceutical that
    would produce the pain relieving effects of
    marijuana without producing the high.
  • Compounds are named for whom or where they were
    synthesized.
  • JWH-018 John W. Huffman
  • HU-210 Hebrew University

10
History
  • 2004 Spice brand products sold on the
    internet and Head shops.
  • 2007-2008 Spice monitoring begins
  • Dec 2008 Two German labs identify JWH-018 in
    Spice products
  • Austria Switzerland ban herbal incense
  • Jan 2009 Two German labs and the National
    Institute of Health Sciences in Japan identify CP
    47,497 in seven Spice products

11
History
  • Jan 2009 Germany banned CP 47,497 and JWH-018
  • Jan 2009 U.S. Customs and Border Patrol report
    a small but verifiable amount of HU-210
  • Feb 2009 France banned CP 47,497, JWH-018, and
    HU-210

12
History
  • Apr 2009 K2 hits the market
  • Aug 2009 UK Advisory Council on the Misuse of
    Drugs advised the government to control some
    synthetic cannabinoids.
  • Sept 2009 K2 was reported in schools in the
    Kansas area.
  • Feb 2010 The single source of K2 in Lawrence,
    KS was raided

13
History
  • Since then the use of synthetic cannabinoids has
    spread like wild fire
  • Several states have enacted emergency legislation
    making it illegal
  • The Federal Government has emergency scheduled
    JWH-018, JWH-073, JWH-250, CP 47,497 (C8 also)
    as of March 1, 2011.
  • HU-210 is already covered under the Federal
    Analogue Act

14
How do these drugs work?
  • They work just like marijuana!
  • They bind to chemical receptors (CB1) in the
    central nervous system designed to bind with
    natural endocannabinoinds manufactured by your
    body.
  • Endocannabinoids are responsible for
    physiological processes
  • Appetite
  • Mood
  • Memory
  • Pain Sensation
  • These drugs are habit forming and slightly
    addictive.

15
How much does it cost?
16
How is it used?
17
What now?
  • Making synthetic cannabinoids illegal is
    problematic
  • How do we test it?
  • Which compounds do we make illegal?
  • Will the Controlled Substances Analog Act cover
    isomers?
  • Where do we get known chemical standards to
    compare street drugs to?
  • How do we testify to something that has yet to be
    researched?

18
Resources
  • www.drugfree.org Forendex
    (SAFS)
  • www.theantidrug.com CLIC_List
  • www.dare.com SWAFS_List
  • www.fairbankscd.org
  • www.wikipedia.org
  • www.jwh-info.com
  • www.erowid.org
  • www.deadiversion.usdoj.gov/drugs_concern/spice/ind
    ex.html

19
Bath Salts, What are they?
  • 3,4-Methylenedioxypyrovalerone (MDPV) is a
    designer drug of the phenethylamine class. MDPV
    is structurally related to cathinone, an active
    alkaloid found in the khat plant,
    3,4-methylenedioxymethamphetamine (MDMA),
    methamphetamine, and other schedule I
    phenethylamines.

Spice A never ending story?
20
Bath Salts, What are they?
  • MDPV, like some other substances in this class,
    is a central nervous system (CNS) stimulant. MDPV
    is also reported to have hallucinogenic effects.

Spice A never ending story?
21
Miami 'zombie' attacker may have been using
'bath salts' -- CNN
  • A naked man who chewed off the face of another
    man in what is being called a zombie-like attack
    may have been under the influence of "bath
    salts," a drug referred to as the new LSD.

Spice A never ending story?
22
Types of Scheduling Actions
  • Administrative
  • Formal
  • Legislative
  • Temporary

23
Activities
  • Reports of abuse and seizure data prompts DEA to
  • Monitor substances through drug seizure and
    supply databases
  • Collect and disseminate scientific information to
    law enforcement
  • Evaluate international trends
  • Coordinate response with other agencies

24
Domestic Scheduling of Controlled Substances
NDA Submission DHHS Initiates
YES
Petition/ Activity DEA Initiates
DEA Review
If accepted
Accepted
Rejected
DEA Enforces
Formal Rulemaking Comments / Hearing ?
YES
DEA Review
DHHS
denotes industry involvement
25
Controlled Substance Act
  • Under the CSA, there are five schedules under
    which substances may be classifiedSchedule I
    being the most restrictive. Substances placed
    onto one of the five schedules are evaluated on

26
Controlled Substance Act
  • actual or relative potential for abuse
  • known scientific evidence of pharmacological
    effects
  • current scientific knowledge of the substance
  • history and current pattern of abuse
  • scope, duration, and significance of abuse
  • risk to public health
  • psychic or physiological dependence liability
    and
  • whether the substance is an immediate precursor
    of an already-scheduled substance.

27
Emergency Scheduling
  • Before a substance may be placed into emergency
    scheduling the following factors must be
    considered
  • History and Current Pattern of Abuse
  • Scope, Duration, and Significance of Abuse
  • What, if any, Risk to Public Health

28
Emergency Scheduling
  • A substance meeting the statutory requirements
    for temporary scheduling (21 U.S.C. 811(h)(1))
    may only be placed in schedule I. Substances in
    schedule I are those that have a high potential
    for abuse, no currently accepted medical use in
    treatment in the United States, and lack accepted
    safety for use under medical supervision.

29
Emergency Scheduling
  • As of March 2011 and October 2011 The following
    were placed as Schedule I Controlled Substances
  • JWH-018
  • JWH-073
  • JWH-200
  • CP-47,497
  • CP-47,497 C8 homologue
  • Mephedrone
  • MDPV
  • Methylone

30
Controlled Substance Analogues
  • The issue of whether a substance is a controlled
    substance analogue is an issue of fact which
    must be determined by a judge or jury.  There are
    three criteria involved in determining whether a
    substance is a controlled substance analogue.

31
Controlled Substance Analogues
  • (1) First, the government must present evidence
    to support a finding that a substance has a
    chemical structure substantially similar to a
    Schedule I or II controlled substance.
  • Then the government must present evidence that
    either

32
Controlled Substance Analogues
  • (2) the substance has a pharmacological effect
    substantially similar or greater than a Schedule
    I or II controlled substance or
  • (3) the substance was represented by the seller
    to have a pharmacological effect substantially
    similar to or greater than a Schedule I or II
    controlled substance (example this acts just
    like MDMA).

33
Current Legislation
  • Several bills have been introduced in the to
    Congress that confront the issue of synthetic
    drug use and abuse
  • There is current legislation being proposed that
    would add 15 cannabimimetic substances and 11
    cathinones, etc., to schedule I (26 substances
    total) of the CSA.

34
(No Transcript)
35
Thanks!
  • Darrell.L.Davis_at_usdoj.gov
  • 972-559-7950
  • Rashad.A.Sims_at_usdoj.gov
  • 972-559-7953
Write a Comment
User Comments (0)
About PowerShow.com